Clinical trial
A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
NCT00000942 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000942 |
|---|---|
| Title | A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies |
| Official title | A Phase III Randomized, Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Pregnancy |
| Intervention type | Drug |
| Interventions | Nevirapine |
| Enrollment | 1,244 |
| Completion | May 1, 2001 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 29, 2021 |
| Countries | France, Italy, Spain, The Bahamas |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: